By Julie Steenhuysen CHICAGO (Reuters) - Cancer patients with COVID-19 who were treated with a drug combination promoted by U.S. President Donald Trump to counter the coronavirus were three times more likely to die within 30 days than those who got either drug alone, U.S. researchers reported on Thursday
The post Hydroxychloroquine combination risky for cancer patients with COVID-19 – study appeared first on Firstpost.
from Firstpost https://ift.tt/3eseTFP
No comments:
Post a Comment